91 related articles for article (PubMed ID: 22630782)
1. The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.
Pepe J; Isidori AM; Falciano M; Iaiani G; Salotti A; Diacinti D; Del Fiacco R; Sbardella E; Cipriani C; Piemonte S; Romagnoli E; Lenzi A; Minisola S
Clin Endocrinol (Oxf); 2012 Nov; 77(5):672-8. PubMed ID: 22630782
[TBL] [Abstract][Full Text] [Related]
2. Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy.
Tsai MS; Zhang JY; Sun HY; Liu WC; Wu PY; Yang CJ; Hung CC
J Int AIDS Soc; 2019 Aug; 22(8):e25383. PubMed ID: 31423752
[TBL] [Abstract][Full Text] [Related]
3. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
4. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease.
Ogura-Tomomatsu H; Asano K; Tomomatsu K; Miyata J; Ohmori N; Kodama M; Ueda S; Takihara T; Tanaka K; Kamiishi N; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Betsuyaku T
COPD; 2012 Aug; 9(4):332-7. PubMed ID: 22489911
[TBL] [Abstract][Full Text] [Related]
5. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
[TBL] [Abstract][Full Text] [Related]
6. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
Calmy A; Fux CA; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr A
J Infect Dis; 2009 Dec; 200(11):1746-54. PubMed ID: 19874178
[TBL] [Abstract][Full Text] [Related]
7. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
8. Comparison of peripheral forearm DXA and clinical risk factor screening using FRAX® to assess the risk of HIV-associated low bone mass: a cross-sectional study.
Short CE; Shaw SG; Fisher MJ; Gilleece YC; Walker-Bone K
Arch Osteoporos; 2014; 9():181. PubMed ID: 24847675
[TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
10. BMD is reduced in HIV-infected men irrespective of treatment.
Amiel C; Ostertag A; Slama L; Baudoin C; N'Guyen T; Lajeunie E; Neit-Ngeilh L; Rozenbaum W; De Vernejoul MC
J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
[TBL] [Abstract][Full Text] [Related]
13. Preventing osteoporotic fractures in older people.
McCloskey E
Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
[TBL] [Abstract][Full Text] [Related]
14. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
[TBL] [Abstract][Full Text] [Related]
15. [Development and application of fracture risk assessments].
Nakamura T
Clin Calcium; 2012 Jun; 22(6):819-24. PubMed ID: 22653019
[TBL] [Abstract][Full Text] [Related]
16. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
[TBL] [Abstract][Full Text] [Related]
17. The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?
Sornay-Rendu E; Munoz F; Delmas PD; Chapurlat RD
J Bone Miner Res; 2010 Oct; 25(10):2101-7. PubMed ID: 20499352
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of FRAX Score without bone mineral density determination and the criteria proposed by the Argentine Osteoporosis Society for the use of antiresorptive therapy in postmenopausal women].
Camporro F; Redondo L; Bulacio E; Gutiérrez Magaldi I; Chamale E; Sáenz F
Medicina (B Aires); 2015; 75(3):155-8. PubMed ID: 26117605
[TBL] [Abstract][Full Text] [Related]
19. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
[TBL] [Abstract][Full Text] [Related]
20. Identification of patient profile for treatment.
Moon RJ; Harvey NC
Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):767-82. PubMed ID: 25432351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
